ADC Bio - International Biopharmaceutical Industry

Current Edition

news

ADC Bio secures £1.14m investment from Downing LLP to finance innovative bioconjugation and US expansion

Funding earmarked for US market penetration and development of groundbreaking upstream bioconjugation approach ADC Biotechnology (ADC Bio), announces that it has sec...

24 April 2018 news ADC Bio | Downing LLP

Continue Reading →

International Biopharmaceutical Industry

IBI – International Biopharmaceutical Industry was established to fill in the void for effective marketing and communication between all stakeholders in the Life sciences sector globally.

Current Edition

Upcoming Events

Advertisement

ADC Bio secures £1.14m investment from Downing LLP to finance innovative bioconjugation and US expansion

International Biopharmaceutical Industry